Gold vs US Dollar

Register to chat with like-minded investors on our interactive forums.

Get Started

Home
Investing
Stocks
USA
NYSE
Abbott Laboratories (ABT)
Abbott Laboratories (ABT) Financials

ABT Abbott Laboratories

114.23

1.81 (1.61%)

21 Dec 2024 - Closed

Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Annual Quarterly

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	10.09B	9.75B	9.98B	10.14B	10.24B	9.96B	10.38B	10.64B
Operating Income	1.3B	1.51B	1.54B	1.65B	1.78B	1.39B	1.67B	1.86B
Pre Tax Income	1.32B	1.56B	1.64B	1.67B	1.8B	1.44B	1.61B	1.94B
Net Income	1.03B	1.32B	1.38B	1.44B	1.59B	1.23B	1.3B	1.65B
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0	0	0	0	0	0	0	0
EBIT	1.37B	1.62B	1.72B	1.73B	1.93B	1.5B	1.66B	1.98B
EBITDA	2.22B	2.32B	2.34B	2.47B	2.69B	2.19B	2.5B	2.66B

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Total Revenue	20.85B	27.39B	30.58B	31.9B	34.61B	43.08B	43.65B	40.11B
Operating Income	3.19B	1.73B	3.65B	4.53B	5.36B	8.43B	8.36B	6.48B
Pre Tax Income	1.41B	2.23B	2.87B	4.08B	4.97B	8.21B	8.31B	6.66B
Net Income	1.4B	477M	2.37B	3.69B	4.5B	7.07B	6.93B	5.72B
Preferred Dividends	0	0	0	0	0	0	0	0
Basic Earnings Per Share (EPS)	0.951	0.274	1.349	2.092	2.538	4.008	3.99	3.297
EBIT	2.24B	2.98B	3.62B	4.66B	5.46B	8.7B	8.68B	7B
EBITDA	4.54B	4.75B	6.93B	7.55B	8.68B	11.96B	11.74B	9.82B

Abbott Laboratories

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions